Tempest Therapeutics Stock Forecast - Simple Regression
| TPST Stock | USD 3.07 0.46 17.62% |
The Simple Regression forecasted value of Tempest Therapeutics on the next trading day is expected to be 0.49 with a mean absolute deviation of 1.51 and the sum of the absolute errors of 92.20. Tempest Stock Forecast is based on your current time horizon.
At this time the rsi of Tempest Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (3.52) | EPS Estimate Current Year (12.78) | EPS Estimate Next Year (16.02) | Wall Street Target Price 9 | EPS Estimate Current Quarter (3.27) |
Using Tempest Therapeutics hype-based prediction, you can estimate the value of Tempest Therapeutics from the perspective of Tempest Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Tempest Therapeutics Hype to Price Pattern
Investor biases related to Tempest Therapeutics' public news can be used to forecast risks associated with an investment in Tempest. The trend in average sentiment can be used to explain how an investor holding Tempest can time the market purely based on public headlines and social activities around Tempest Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
The Simple Regression forecasted value of Tempest Therapeutics on the next trading day is expected to be 0.49 with a mean absolute deviation of 1.51 and the sum of the absolute errors of 92.20.
Tempest Therapeutics after-hype prediction price | USD 3.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Tempest Therapeutics to cross-verify your projections. Tempest Therapeutics Additional Predictive Modules
Most predictive techniques to examine Tempest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tempest using various technical indicators. When you analyze Tempest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Tempest Therapeutics Simple Regression Price Forecast For the 24th of January
Given 90 days horizon, the Simple Regression forecasted value of Tempest Therapeutics on the next trading day is expected to be 0.49 with a mean absolute deviation of 1.51, mean absolute percentage error of 2.91, and the sum of the absolute errors of 92.20.Please note that although there have been many attempts to predict Tempest Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Tempest Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Tempest Therapeutics Stock Forecast Pattern
| Backtest Tempest Therapeutics | Tempest Therapeutics Price Prediction | Buy or Sell Advice |
Tempest Therapeutics Forecasted Value
In the context of forecasting Tempest Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Tempest Therapeutics' downside and upside margins for the forecasting period are 0.03 and 9.36, respectively. We have considered Tempest Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Tempest Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Tempest Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.1771 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.5114 |
| MAPE | Mean absolute percentage error | 0.3814 |
| SAE | Sum of the absolute errors | 92.1952 |
Predictive Modules for Tempest Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tempest Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tempest Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Tempest Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Tempest Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tempest Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tempest Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Tempest Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Tempest Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tempest Therapeutics' historical news coverage. Tempest Therapeutics' after-hype downside and upside margins for the prediction period are 0.16 and 12.07, respectively. We have considered Tempest Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Tempest Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Tempest Therapeutics is based on 3 months time horizon.
Tempest Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Tempest Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tempest Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tempest Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.58 | 8.87 | 0.11 | 0.12 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.07 | 3.18 | 3.58 |
|
Tempest Therapeutics Hype Timeline
Tempest Therapeutics is at this time traded for 3.07. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of -0.12. Tempest is projected to increase in value after the next headline, with the price projected to jump to 3.18 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 3.58%, whereas the daily expected return is at this time at -1.58%. The volatility of related hype on Tempest Therapeutics is about 12150.68%, with the expected price after the next announcement by competition of 2.95. Tempest Therapeutics currently holds 15.37 M in liabilities with Debt to Equity (D/E) ratio of 0.49, which is about average as compared to similar companies. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Historical Fundamental Analysis of Tempest Therapeutics to cross-verify your projections.Tempest Therapeutics Related Hype Analysis
Having access to credible news sources related to Tempest Therapeutics' direct competition is more important than ever and may enhance your ability to predict Tempest Therapeutics' future price movements. Getting to know how Tempest Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tempest Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OKUR | OnKure Therapeutics | 0.07 | 9 per month | 4.33 | 0.03 | 9.79 | (6.92) | 23.27 | |
| KZR | Kezar Life Sciences | (0.04) | 10 per month | 0.15 | 0.10 | 1.60 | (1.27) | 57.13 | |
| FGEN | FibroGen | (1.07) | 7 per month | 0.00 | (0.08) | 4.33 | (5.28) | 28.75 | |
| ALGS | Aligos Therapeutics | 0.35 | 10 per month | 0.00 | (0.03) | 10.16 | (8.73) | 28.43 | |
| MRSN | Mersana Therapeutics | 0.05 | 5 per month | 2.27 | 0.13 | 7.25 | (6.26) | 210.61 | |
| XLO | Xilio Development | 0.01 | 13 per month | 0.00 | (0.14) | 4.69 | (5.56) | 15.41 | |
| PDSB | PDS Biotechnology Corp | (0.03) | 8 per month | 4.56 | 0.02 | 8.60 | (8.41) | 27.78 | |
| ATNM | Actinium Pharmaceuticals | 0.07 | 10 per month | 0.00 | (0.03) | 6.29 | (5.33) | 25.17 | |
| BRNS | Barinthus Biotherapeutics plc | 0.02 | 7 per month | 0.00 | (0.21) | 5.71 | (9.09) | 24.01 | |
| INMB | INmune Bio | (0.16) | 36 per month | 0.00 | (0.03) | 6.81 | (7.51) | 21.68 |
Other Forecasting Options for Tempest Therapeutics
For every potential investor in Tempest, whether a beginner or expert, Tempest Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Tempest Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Tempest. Basic forecasting techniques help filter out the noise by identifying Tempest Therapeutics' price trends.Tempest Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tempest Therapeutics stock to make a market-neutral strategy. Peer analysis of Tempest Therapeutics could also be used in its relative valuation, which is a method of valuing Tempest Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Tempest Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Tempest Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tempest Therapeutics shares will generate the highest return on investment. By undertsting and applying Tempest Therapeutics stock market strength indicators, traders can identify Tempest Therapeutics entry and exit signals to maximize returns.
Tempest Therapeutics Risk Indicators
The analysis of Tempest Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Tempest Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tempest stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.67 | |||
| Standard Deviation | 8.59 | |||
| Variance | 73.82 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Tempest Therapeutics
The number of cover stories for Tempest Therapeutics depends on current market conditions and Tempest Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tempest Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tempest Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Tempest Therapeutics Short Properties
Tempest Therapeutics' future price predictability will typically decrease when Tempest Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tempest Therapeutics often depends not only on the future outlook of the potential Tempest Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tempest Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.9 M | |
| Cash And Short Term Investments | 30.3 M |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.